Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.

dc.contributor.author	Kisacik, Bunyamin
dc.contributor.author	Pamuk, Omer
dc.contributor.author	Onat, Ahmet Mesut
dc.contributor.author	Erer, B.
dc.contributor.author	Hatemi, Gulen
dc.contributor.author	Ozguler, Yesim
dc.contributor.author	Ozbek, Suleyman
dc.date.accessioned	2020-06-21T13:52:47Z
dc.date.available	2020-06-21T13:52:47Z
dc.date.issued	2014
dc.identifier.issn	2326-5191
dc.identifier.issn	2326-5205
dc.identifier.uri	https://hdl.handle.net/20.500.12712/14922
dc.description	WOS: 000344384904305	en_US
dc.description.abstract	…	en_US
dc.language.iso	eng	en_US
dc.publisher	Wiley-Blackwell	en_US
dc.rights	info:eu-repo/semantics/closedAccess	en_US
dc.title	Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.	en_US
dc.type	conferenceObject	en_US
dc.contributor.department	OMÜ	en_US
dc.identifier.volume	66	en_US
dc.identifier.startpage	S943	en_US
dc.identifier.endpage	S943	en_US
dc.relation.journal	Arthritis & Rheumatology	en_US
dc.relation.publicationcategory	Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı	en_US

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.